Medicus Pharma Ltd. (MDCX) stock

MDCXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as MDCXW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30

$1.95+0.23 (+13.37%)

Close on Nov 13, 2026Market cap $3.61MP/E –Yield –

Medicus Pharma statistics

52 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $3.61M; $272.32M
Enterprise Value: -$1.36M; $146.23M

Share statisticsIndustry

Shares Outstanding: 2M; 58M
Shares Change (YoY): 197.9%; 10.8%
Shares Change (QoQ): 53.8%; 0.50%
Shares Held by Institutions: 6.01%; 56.4%

Short sellingIndustry

Short Interest: 62,056; –
Short Interest Change: 42.2%; -0.80%
Days to Cover: 1.00; 5.15

Stock price statisticsIndustry

52-Week High: $127.50; –
52-Week Low: $1.63; –
20-Day Moving Average: $2.16; –
50-Day Moving Average: $5.12; –
200-Day Moving Average: $19.68; –
Average True Range (14): $0.40; –
Price Change (1 Week): 4.28%; -1.15%
Price Change (1 Month): -43.1%; -4.87%
Price Change (3 Months): -85.0%; -21.0%
Price Change (6 Months): -87.0%; -20.6%
Price Change (YTD): -97.5%; -23.6%
Price Change (1 Year): -98.4%; -22.4%
Average Volume (10 Days): 65,392; –
Average Volume (20 Days): 65,996; –
Average Volume (90 Days): 88,563; –
Relative Volume: 0.54; 0.70
Relative Strength Index (14): 27.2; 43.4
Volatility (1 Year): 136.1%; 80.1%
Beta (5 Years): 1.45; 1.07

Returns on capitalIndustry

Return on Assets (ROA): -415.3%; -40.6%
Return on Capital Employed (ROCE): -883.0%; -37.9%

Financial positionIndustry

Current Ratio: 0.65; 3.30
Quick Ratio: 0.52; 2.39

EfficiencyIndustry

Profits Per Employee: -$3.18M; -$689.41K
Employee Count: 16; 74
WACC: 12.4%; 10.2%

Income statement (TTM)Industry

Operating Income: -$42.33M; -$21.37M
Net Income: -$50.91M; -$22.35M
EBITDA: -$42.33M; -$17.21M
EPS (Diluted): -$78.14; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $5.02M; $68.68M
Net Cash (Debt): $5.02M; $17.76M
Net Cash Per Share: $2.71; $0.80
Equity (Book Value): -$10.54M; $53.89M
Book Value Per Share: -$5.69; $1.50
Tangible Book Value: -$10.54M; $27.13M
Working Capital: -$3.37M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$38.50M; -$12.38M

Dividends and yieldsIndustry

Earnings Yield: -1410.9%; -21.8%
Buyback Yield: 0.00%; -0.76%
Shareholder Yield: 0.00%; 0.00%

Scores and fair valueIndustry

Altman Z-Score: -19.45; 0.23
Piotroski F-Score: 2; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MDCX	S&P 500	Difference
1 month	-40.5%	-3.0%	−37.5 pts
3 months	-89.0%	-2.8%	−86.2 pts
Year to date	-97.5%	+11.5%	−108.9 pts
1 year	-98.3%	+13.5%	−111.7 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M MDCX shares were sold short on Oct 30, 2026, up 42.2% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 44.3% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	62,056	+42.2%	62,810	1.0
Oct 15, 2026	43,628	-98.8%	116,893	1.0
Sep 30, 2026	3,686,994	-26.2%	3,918,492	1.0
Sep 15, 2026	4,998,570	+49.0%	16,776,075	1.0
Aug 31, 2026	3,355,388	+20.3%	1,296,885	2.6
Aug 14, 2026	2,788,116	-7.3%	1,752,277	1.6
Jul 31, 2026	3,007,583	+5.9%	1,668,854	1.8
Jul 15, 2026	2,838,930	+171.5%	1,143,133	2.5
Jun 30, 2026	1,045,598	-45.8%	2,653,037	1.0
Jun 15, 2026	1,928,591	-35.4%	1,878,019	1.0
May 29, 2026	2,984,551	+36.0%	2,912,561	1.0
May 15, 2026	2,194,289	+24.5%	2,643,698	1.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?